Sumitomo Mitsui Trust Holdings, Inc. Editas Medicine, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$145 Billion
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	SELL	$12.16 - $19.42 $4.78 Million - $7.63 Million	-392,717 Reduced 52.46%	355,836 $4.36 Million
Q2 2022 Jul 26, 2022	SELL	$9.99 - $21.35 $2.83 Million - $6.05 Million	-283,560 Reduced 27.47%	748,553 $8.86 Million
Q1 2022 Apr 27, 2022	SELL	$14.08 - $27.63 $23.1 Million - $45.4 Million	-1,643,122 Reduced 61.42%	1,032,113 $19.6 Million
Q4 2021 Feb 02, 2022	SELL	$26.55 - $40.57 $42.1 Million - $64.4 Million	-1,587,337 Reduced 37.24%	2,675,235 $71 Million
Q3 2021 Oct 25, 2021	SELL	$39.27 - $72.94 $24.1 Million - $44.8 Million	-613,847 Reduced 12.59%	4,262,572 $175 Million
Q2 2021 Aug 02, 2021	BUY	$31.29 - $56.64 $20.5 Million - $37 Million	653,617 Added 15.48%	4,876,419 $276 Million
Q1 2021 Apr 30, 2021	SELL	$39.71 - $90.58 $6.57 Million - $15 Million	-165,341 Reduced 3.77%	4,222,802 $177 Million
Q4 2020 Feb 05, 2021	SELL	$27.07 - $84.35 $18.6 Million - $57.9 Million	-685,965 Reduced 13.52%	4,388,143 $308 Million
Q3 2020 Oct 30, 2020	BUY	$28.06 - $37.16 $2.14 Million - $2.83 Million	76,279 Added 1.53%	5,074,108 $142 Million
Q2 2020 Jul 27, 2020	SELL	$18.5 - $34.34 $2.03 Million - $3.77 Million	-109,848 Reduced 2.15%	4,997,829 $148 Million
Q1 2020 Apr 27, 2020	BUY	$14.88 - $32.78 $2.37 Million - $5.23 Million	159,450 Added 3.22%	5,107,677 $101 Million
Q4 2019 Jan 31, 2020	SELL	$19.49 - $32.63 $202,033 - $338,242	-10,366 Reduced 0.21%	4,948,227 $147 Million
Q3 2019 Oct 31, 2019	BUY	$22.49 - $26.81 $77.4 Million - $92.3 Million	3,443,666 Added 227.32%	4,958,593 $113 Million
Q2 2019 Jul 29, 2019	BUY	$20.48 - $27.76 $16.2 Million - $22 Million	792,931 Added 109.82%	1,514,927 $37.5 Million
Q1 2019 May 08, 2019	BUY	$19.43 - $26.41 $14 Million - $19.1 Million	721,996 New	721,996 $17.7 Million

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

56.8M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$10.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.75 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.42 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.39 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.23 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account